AzTrials
AzTrials

Iron Deficiency AnemiaNCT04131608

Effect of Iron Deficiency Anemia on HBA1C in Patients With Diabetic Foot Ulcer Grade (1and2)

An observational study of Iron Deficiency Anemia and HBA1C, run by Assiut University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Diabetic foot ulcer is the commonest cause of severe limb ischemia in diabetes mellitus And development of anemia is an additional burden to the microvascular complications of diabetes Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Iron Deficiency Anemia, HBA1C
What is being tested?
CBC ,Serum ferritin ,HBA1C
How many people
100 participants
Where
No sites listed yet
Study dates
1 Feb 2021to 1 Dec 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Diabetic patients with diabetic foot ulcer grade one and two with or without iron deficiency anemia

Who may be able to join

  • all diabetic patients with diabetic foot ulcer grade one and two above 18 year

Who cannot join

  • patients with anemia other than iron deficiency anemia
  • Patients on anticoagulants
  • patients with blood disease 4-patients below 18

Trial locations and contacts

No sites are listed yet.

Marina Samir Fawzy, Resident contact

01271389378

Drmarinasamirfawzy@gmail.com

Manal Al Sayed Ezz El Deen, Associated professor contact

01005826070

Manal_ezeldeen@yahoo.com

About this study

Diabetic foot ulcer is the commonest cause of severe limb ischemia in diabetes mellitus And development of anemia is an additional burden to the microvascular complications of diabetes

Read the detailed description

HBA1C is the predominant Hemoglobin found in HBA1 fraction and it constitutes 5% of total Hemoglobin in normal adults and up to 15%in patients with diabetes mellitus HBA1C is used to diagnose diabetes and to identify individuals that are at high risk for developing diabetes Iron deficiency anemia is one of the most prevalent form of malnutrition affect 1,62 billion people whish correspond to 24,8%of the world population Ferritin is the storage form of iron so it is found to be test for distinguishing those with iron deficiency anemia from those who are not iron deficient

Being tested
CBC ,Serum ferritin ,HBA1C
Medical subject headings
Anemia, Iron-Deficiency

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CBC ,Serum ferritin ,HBA1CDiagnostic test

    Also called Ankle brachial index by duplex

    Diabetic patients will be applied to CBC, HBA1C and serum ferritin

Study groups in NCT04131608
Study groupRoleWhat they receive
diabetic foot ulcer (1and2)with iron defic50 diabetic patients with diabetic foot ulcer grade (1and2) with iron deficiency anemia will be applied TO 1. cbc 2. ferritin 3. HBA1C 4. ankle brachial index by duplex
Receives: Diagnostic Test: CBC ,Serum ferritin ,HBA1C
diabetic foot ulcer grade(1and2)without iron deficiency anemia50 patients with diabetic foot ulcer grade (1and2) without iron deficiency anemia will be applied to 1. CBC 2. Ferritin, 3. HBA1C 4. ankle brachial index by duplex
Receives: Diagnostic Test: CBC ,Serum ferritin ,HBA1C

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Iron deficiency detected by Hemoglobin level in g/dl HBA1C level in diabetic patients

    The influence of iron deficiency anemia on HBA1C in diabetic patients

    Measured: Base line

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Oct 2019
  2. Study start1 Feb 2021 (estimated)
  3. Primary completion1 Oct 2021 (estimated)
  4. Study completion1 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04131608
Sponsor's protocol ID
HBA1C and anemia
Status last verified
Oct 2020
First submitted
25 Sep 2019
Last updated
13 Jan 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Kim S, Min WK, Chun S, Lee W, Park HI. Glycated albumin may be a possible alternative to hemoglobin A1c in diabetic patients with anemia. Clin Chem Lab Med. 2011 Oct;49(10):1743-7. doi: 10.1515/CCLM.2011.646. Epub 2011 Jun 17.

    PubMed 21679130
  • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010 Jan;33 Suppl 1(Suppl 1):S62-9. doi: 10.2337/dc10-S062. No abstract available.

    PubMed 20042775
  • Kim C, Bullard KM, Herman WH, Beckles GL. Association between iron deficiency and A1C Levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care. 2010 Apr;33(4):780-5. doi: 10.2337/dc09-0836. Epub 2010 Jan 12.

    PubMed 20067959
  • Wolffenbuttel BH, Herman WH, Gross JL, Dharmalingam M, Jiang HH, Hardin DS. Ethnic differences in glycemic markers in patients with type 2 diabetes. Diabetes Care. 2013 Oct;36(10):2931-6. doi: 10.2337/dc12-2711. Epub 2013 Jun 11.

    PubMed 23757434
  • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014 Jan;37 Suppl 1:S81-90. doi: 10.2337/dc14-S081. No abstract available.

    PubMed 24357215

Questions about this trial

What is this clinical trial studying?

An observational study of Iron Deficiency Anemia and HBA1C, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Jan 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Marina Samir Fawzy, Resident (01271389378, Drmarinasamirfawzy@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Iron deficiency detected by Hemoglobin level in g/dl HBA1C level in diabetic patients (time frame: Base line). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04131608, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jan 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in